$1.5096
0.0396[2.69%]
At close: Apr 17
$1.5096
0[0.00%]
After Hours: 9:05AM EDT
Spero Therapeutics
(NASDAQ:SPRO)Overview Rating
Very Promising
Spero Therapeutics Stock (NASDAQ:SPRO), Quotes and News Summary
Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
| Open | $1.470 |
| Close | $1.500 |
| Volume / Avg. | 208.977K / 314.305K |
| Day Range | 1.470 - 1.530 |
| 52 Wk Range | 0.990 - 1.995 |
| Market Cap | $81.321M |
| P/E Ratio | 3.430 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 1.47% |
| Days to Cover | 2.09 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Spero Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, develo...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Spero Therapeutics (SPRO) stock?
You can purchase shares of Spero Therapeutics (NASDAQ: SPRO) through any online brokerage.
Who are Spero Therapeutics's (SPRO) competitors?
Other companies in Spero Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Spero Therapeutics (SPRO) stock?
The latest price target for Spero Therapeutics (NASDAQ: SPRO) was reported by Cantor Fitzgerald on Thursday, April 4, 2024. The analyst firm set a price target for 0.00 expecting SPRO to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Spero Therapeutics (SPRO)?
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.5096 last updated April 17, 2024 at 9:05 AM EDT.
Does Spero Therapeutics (SPRO) pay a dividend?
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?
Spero Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Spero Therapeutics (SPRO) going to split?
There is no upcoming split for Spero Therapeutics.
What sector and industry does Spero Therapeutics (SPRO) operate in?
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.